Table 3.
Multivariate analyses therapeutic decision (BMS vs DES)
| Bivariate analyses (OR) | Multivariate analyses (OR) | p value* | |
| Total population ( n = 442) | |||
| Number of diseased vessels | |||
| 1 | 0.520 | 0.560 | 0.006 |
| > 1 | Ref | ||
| NYHA class | |||
| NYHA class I | Ref | ||
| NYHA class II | 1.478 | ||
| NYHA class III + IV | 5.311 | ||
| Hospital | |||
| 1 | 0.565 | ||
| 2 | 1.016 | ||
| 3 | 45.176 | ||
| 4 | Ref | ||
| Diabetes (yes vs no) | 8.680 | 8.318 | p < 0.001 |
| Renal artery disease (yes vs no) | 0.368 | ||
| Current smoker (yes vs no) | 0.599 | ||
| Previous MI (yes vs no) | 1.486 | ||
| PVD (yes vs no) | 1.017 | ||
| Previous PTCA (yes vs no) | 2.045 | ||
| TIMI score a | |||
| 1 | Ref | ||
| 2 | 1.20 | ||
| 3 | 0.37 | ||
| 4 | 2.000 | ||
| 5 | 0.600 | ||
| 6 + 7 | 646189937 | ||
| Constant | 1.911 | p < 0.001 | |
| Nagelkerke R2 | 16 % | ||
| Stable CAD (n = 358) | Bivariate analyses (OR) | Multivariate analyses (OR) | p value* |
| BMI (kg/m 2) | 1.049 | ||
| Hospital | |||
| 1 | 0.578 | 0.466 | 0.013 |
| 2 | 1.034 | 1.047 | 0.884 |
| 3 | 26.671 | 29.381 | 0.001 |
| 4 | Ref | Ref | |
| Previous MI (yes vs no) | 1.513 | ||
| NYHA class | |||
| NYHA class I | Ref | ||
| NYHA class II | 1.280 | ||
| NYHA class III + IV | 4.319 | ||
| Number of diseased vessels | |||
| 1 | 0.536 | ||
| > 1 | Ref | ||
| Current smoker (yes vs no) | 0.588 | 0.404 | 0.014 |
| Diabetes (yes vs no) | 8.454 | 12.001 | p < 0.001 |
| Previous PTCA (yes vs no) | 2.103 | 2.284 | 0.003 |
| Constant | 1.207 | 0.397 | |
| Nagelkerke R2 | 33 % | ||
| Unstable CAD (n = 84) | Bivariate analyses (OR) | Multivariate analyses (OR) | p value* |
| Hospital | |||
| 1 | 0.686 | ||
| 2 | 1.000 | ||
| 3 | 1346229036 | ||
| 4 | Ref | ||
| NYHA class | |||
| NYHA class I | Ref | ||
| NYHA class II | 1105324892 | ||
| NYHA class III + IV | 8.895 | ||
| Diabetes (yes vs no) | 10.146 | 10.146 | 0.029 |
| TIMI score a | |||
| 1 | Ref | ||
| 2 | 1.600 | ||
| 3 | 0.369 | ||
| 4 | 1.900 | ||
| 5 | 0.600 | ||
| 6 + 7 | 646189937 | ||
| SBP (mmHg) | 1.007 | ||
| Constant | 1.577 | 0.069 | |
| Nagelkerke R 2 | 13 % | ||
SBP systolic blood pressure, BMI body mass index, NYHA New York heart association, PTCA percutaneous transluminal coronary angioplasty, TIMI Thrombolysis In Myocardial Infarction.
aP value of multivariate analyses.
*p = 0.05